Gasotransmitter delivery via self-assembling peptides: Treating diseases with natural signaling gases

Advanced Drug Delivery Reviews

Volumn 110-111, Issue , 2017, Pages 137-156

  Qian, Yun ^a   Matson, John B ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Aromatic peptide amphiphiles; Beta sheet; Inhalation therapy; Peptide amphiphiles; Peptide nanostructures; Self assembly

Indexed keywords

AMPHIPHILES; BIODEGRADABILITY; CARBON; CARBON MONOXIDE; CHEMICAL MODIFICATION; GELS; MAMMALS; NITRIC OXIDE; RESPIRATORY THERAPY; SELF ASSEMBLY;

ATTRACTIVE STRATEGIES; BETA-SHEET; CONTROLLED DELIVERY; INHALATION THERAPY; INHERENT BIODEGRADABILITIES; PEPTIDE AMPHIPHILES; SELF-ASSEMBLING PEPTIDES; THERAPEUTIC POTENTIALS;

PEPTIDES;

ACETYLSALICYLIC ACID; AMPHOPHILE; AROMATIC PEPTIDE AMPHIPHILE DERIVATIVE; CARBON MONOXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLYCERYL TRINITRATE; GUANOSINE TRIPHOSPHATE; HEME OXYGENASE 1; HEME OXYGENASE 2; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; METAL ORGANIC FRAMEWORK; N ACETYL S NITROSOPENICILLAMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG; VASCULOTROPIN; GASOTRANSMITTER; PEPTIDE;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BIOCOMPATIBILITY; BIODEGRADABILITY; BLEEDING; BLOODSTREAM INFECTION; CARDIOVASCULAR DISEASE; CELL PROTECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; ENZYME DEGRADATION; GRAFT REJECTION; HALF LIFE TIME; HUMAN; HYPERPLASIA; LUNG FIBROSIS; MALIGNANT NEOPLASM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PEPTIDE ANALYSIS; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN MOTIF; PROTEIN STRUCTURE; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REVIEW; THROMBOSIS; WOUND HEALING; ANIMAL; METABOLISM; PROCEDURES; SYNTHESIS;

ANIMALS; CARBON MONOXIDE; DRUG DELIVERY SYSTEMS; GASOTRANSMITTERS; HUMANS; HYDROGEN SULFIDE; NITRIC OXIDE; PEPTIDES;

EID: 84979582566     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.06.017     Document Type: Review

References (217)

1. Scheele, C.W., Forster, J.R., Priestley, J., Kirwan, R., Bergman, T., Chemical Observations and Experiments on Air and Fire. printed for, 1780, J. Johnson.
2. Wang, R., Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol. Rev. 92 (2012), 791–896.
3. Szabo, C., Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6 (2007), 917–935.
4. Weinberger, B., Laskin, D.L., Heck, D.E., Laskin, J.D., The toxicology of inhaled nitric oxide. Toxicol. Sci. 59 (2001), 5–16.
5. Douglas, C.G., Haldane, J.S., Haldane, J.B.S., The laws of combination of hæmoglobin with carbon monoxide and oxygen. J. Physiol. 44 (1912), 275–304.
6. Haldane, J.B.S., Carbon monoxide as a tissue poison. Biochem. J. 21 (1927), 1068–1075.
7. Arnold, W.P., Mittal, C.K., Katsuki, S., Murad, F., Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. U. S. A. 74 (1977), 3203–3207.
8. Furchgott, R.F., Zawadzki, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980), 373–376.
9. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., Chaudhuri, G., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), 9265–9269.
10. Palmer, R.M., Ferrige, A., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987), 524–526.
11. Carpenter, A.W., Schoenfisch, M.H., Nitric oxide release: Part II. Therapeutic applications. Chem. Soc. Rev. 41 (2012), 3742–3752.
12. Sjöstrand, T., Endogenous formation of carbon monoxide. The CO concentration in the inspired and expired air of hospital patients. Acta Physiol. Scand. 22 (1951), 137–141.
13. Marks, G.S., Brien, J.F., Nakatsu, K., McLaughlin, B.E., Does carbon monoxide have a physiological function?. Trends Pharmacol. Sci. 12 (1991), 185–188.
14. Verma, A., Hirsch, D.J., Glatt, C.E., Ronnett, G.V., Snyder, S.H., Carbon monoxide: a putative neural messenger. Science 259 (1993), 381–384.
15. Rattan, S., Chakder, S., Inhibitory effect of CO on internal anal sphincter: heme oxygenase inhibitor inhibits NANC relaxation. Am. J. Physiol. Gastrointest. Liver Physiol. 265 (1993), G799–G804.
16. Suematsu, M., Kashiwagi, S., Sano, T., Goda, N., Shinoda, Y., Ishimura, Y., Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem. Biophys. Res. Commun. 205 (1994), 1333–1337.
17. Fiedler, H., Wood, J.L., Specificity studies on the β-mercaptopyruvate-cyanide transsulfuration system. J. Biol. Chem. 222 (1956), 387–397.
18. Braunstein, A., Goryachenkova, E., Lac, N.D., Reactions catalysed by serine sulfhydrase from chicken liver. Biochim. Biophys. Acta, Enzymol. 171 (1969), 366–368.
19. Radcliffe, B., Egan, A., A survey of methionine adenosyltransferase and cystathionine. Aust. J. Biol. Sci. 27 (1974), 465–472.
20. Abe, K., Kimura, H., The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16 (1996), 1066–1071.
21. Hosoki, R., Matsuki, N., Kimura, H., The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 237 (1997), 527–531.
22. 2S in rat tissues. Can. J. Physiol. Pharmacol. 81 (2003), 848–853.
23. Holmes, T.C., Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol. 20 (2002), 16–21.
24. Altunbas, A., Pochan, D.J., Peptide-based and polypeptide-based hydrogels for drug delivery and tissue engineering. Peptide-Based Materials, 2012, Springer, 135–167.
25. 2S be the third endogenous gaseous transmitter?. FASEB J. 16 (2002), 1792–1798.
26. Wang, R., Gasotransmitters: growing pains and joys. Trends Biochem. Sci. 39 (2014), 227–232.
27. Cary, S.P., Winger, J.A., Derbyshire, E.R., Marletta, M.A., Nitric oxide signaling: no longer simply on or off. Trends Biochem. Sci. 31 (2006), 231–239.
28. Bloch, K.D., Ichinose, F., Roberts, J.D., Zapol, W.M., Inhaled NO as a therapeutic agent. Cardiovasc. Res. 75 (2007), 339–348.
29. Keefer, L.K., Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu. Rev. Pharmacol. Toxicol. 43 (2003), 585–607.
30. Riccio, D.A., Schoenfisch, M.H., Nitric oxide release: part I. Macromolecular scaffolds. Chem. Soc. Rev. 41 (2012), 3731–3741.
31. Loscalzo, J., Antiplatelet and antithrombotic effects of organic nitrates. Am. J. Cardiol. 70 (1992), B18–B22.
32. de Mel, A., Murad, F., Seifalian, A.M., Nitric oxide: a guardian for vascular grafts?. Chem. Rev. 111 (2011), 5742–5767.
33. Wink, D.A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M.W., Mitchell, J.B., The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19 (1998), 711–721.
34. Hirst, D., Robson, T., Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. Curr. Pharm. Des. 16 (2010), 411–420.
35. Masters, K.S.B., Leibovich, S.J., Belem, P., West, J.L., Poole-Warren, L.A., Effects of nitric oxide releasing poly(vinyl alcohol) hydrogel dressings on dermal wound healing in diabetic mice. Wound Repair Regen. 10 (2002), 286–294.
36. Lee, P.C., Salyapongse, A.N., Bragdon, G.A., Shears, L.L., Watkins, S.C., Edington, H.D., Billiar, T.R., Impaired wound healing and angiogenesis in eNOS-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 277 (1999), H1600–H1608.
37. Seabra, A.B., Martins, D., Simões, M.M.S.G., Da Silva, R., Brocchi, M., De Oliveira, M.G., Antibacterial nitric oxide-releasing polyester for the coating of blood-contacting artificial materials. Artif. Organs 34 (2010), E204–E214.
38. Vumma, R., Bang, C.S., Kruse, R., Johansson, K., Persson, K., Antibacterial effects of nitric oxide on uropathogenic Escherichia coli during bladder epithelial cell colonization—a comparison with nitrofurantoin. J. Antibiot., 2015.
39. Motterlini, R., Otterbein, L.E., The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 9 (2010), 728–743.
40. Motterlini, R., Mann, B.E., Foresti, R., Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin. Invest. Drugs 14 (2005), 1305–1318.
41. Boczkowski, J., Poderoso, J.J., Motterlini, R., CO–metal interaction: vital signaling from a lethal gas. Trends Biochem. Sci. 31 (2006), 614–621.
42. Gibbons, S.J., Farrugia, G., The role of carbon monoxide in the gastrointestinal tract. J. Physiol. 556 (2004), 325–336.
43. Hartsfield, C.L., McMurtry, I.F., Ivy, D.D., Morris, K.G., Vidmar, S., Rodman, D.M., Fagan, K.A., Cardioprotective and vasomotor effects of HO activity during acute and chronic hypoxia. Am. J. Physiol. Heart Circ. Physiol. 287 (2004), H2009–H2015.
44. Otterbein, L.E., Bach, F.H., Alam, J., Soares, M., Hong, T.L., Wysk, M., Davis, R.J., Flavell, R.A., Choi, A.M.K., Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6 (2000), 422–428.
45. Bathoorn, E., Slebos, D.J., Postma, D.S., Koeter, G.H., van Oosterhout, A.J., van der Toorn, M., Boezen, H.M., Kerstjens, H.A., Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur. Respir. J. 30 (2007), 1131–1137.
46. Clark, J.E., Naughton, P., Shurey, S., Green, C.J., Johnson, T.R., Mann, B.E., Foresti, R., Motterlini, R., Cardioprotective actions by a water-soluble carbon monoxide–releasing molecule. Circ. Res. 93 (2003), e2–e8.
47. Zuckerbraun, B.S., Billiar, T.R., Otterbein, S.L., Kim, P.K.M., Liu, F., Choi, A.M.K., Bach, F.H., Otterbein, L.E., Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J. Exp. Med. 198 (2003), 1707–1716.
48. McDaid, J., Yamashita, K., Chora, A., Ollinger, R., Strom, T.B., Li, X.C., Bach, F.H., Soares, M.P., Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J. 19 (2005), 458–460.
49. Zuckerbraun, B.S., Chin, B.Y., Wegiel, B., Billiar, T.R., Czsimadia, E., Rao, J., Shimoda, L., Ifedigbo, E., Kanno, S., Otterbein, L.E., Carbon monoxide reverses established pulmonary hypertension. J. Exp. Med. 203 (2006), 2109–2119.
50. Zheng, L., Zhou, Z., Lin, L., Alber, S., Watkins, S., Kaminski, N., Choi, A.M., Morse, D., Carbon monoxide modulates alpha-smooth muscle actin and small proline rich-1a expression in fibrosis. Am. J. Respir. Cell Mol. Biol. 41 (2009), 85–92.
51. Vítek, L., Gbelcová, H., Muchová, L., Váňová, K., Zelenka, J., Koníčková, R., Šuk, J., Zadinova, M., Knejzlík, Z., Ahmad, S., Antiproliferative effects of carbon monoxide on pancreatic cancer. Dig. Liver Dis. 46 (2014), 369–375.
52. Kimura, H., Hydrogen sulfide: from brain to gut. Antioxid. Redox Signal. 12 (2010), 1111–1123.
53. ATP channel opener. EMBO J. 20 (2001), 6008–6016.
54. Baskar, R., Bian, J., Hydrogen sulfide gas has cell growth regulatory role. Eur. J. Pharmacol. 656 (2011), 5–9.
55. Ji, Y., Pang, Q.F., Xu, G., Wang, L., Wang, J.F., Zeng, Y.M., Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia–reperfusion injury. Eur. J. Pharmacol. 587 (2008), 1–7.
56. Taniguchi, S., Kang, L., Kimura, T., Niki, I., Hydrogen sulphide protects mouse pancreatic β-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. Br. J. Pharmacol. 162 (2011), 1171–1178.
57. Papapetropoulos, A., Pyriochou, A., Altaany, Z., Yang, G., Marazioti, A., Zhou, Z., Jeschke, M.G., Branski, L.K., Herndon, D.N., Wang, R., Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 21972–21977.
58. Elrod, J.W., Calvert, J.W., Morrison, J., Doeller, J.E., Kraus, D.W., Tao, L., Jiao, X., Scalia, R., Kiss, L., Szabo, C., Hydrogen sulfide attenuates myocardial ischemia–reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 15560–15565.
59. Polhemus, D.J., Calvert, J.W., Butler, J., Lefer, D.J., The cardioprotective actions of hydrogen sulfide in acute myocardial infarction and heart failure. Scientifica, 2014, 2014, 8.
60. Lee, Z.W., Zhou, J., Chen, C.S., Zhao, Y., Tan, C.H., Li, L., Moore, P.K., Deng, L.W., The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS One, 6, 2011, e21077.
61. Zhen, Y., Pan, W., Hu, F., Wu, H., Feng, J., Zhang, Y., Chen, J., Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-kappaB pathway in PLC/PRF/5 hepatoma cells. Int. J. Oncol. 46 (2015), 2194–2204.
62. Wu, D., Si, W., Wang, M., Lv, S., Ji, A., Li, Y., Hydrogen sulfide in cancer: friend or foe?. Nitric Oxide 50 (2015), 38–45.
63. Wang, R., Shared signaling pathways among gasotransmitters. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 8801–8802.
64. Volpato, G.P., Searles, R., Yu, B., Scherrer-Crosbie, M., Bloch, K.D., Ichinose, F., Zapol, W.M., Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology, 108, 2008, 659.
65. Faller, S., Ryter, S.W., Choi, A., Loop, T., Schmidt, R., Hoetzel, A., Inhaled hydrogen sulfide protects against ventilator-induced lung injury. Anesthesiology 113 (2010), 104–115.
66. Pacher, P., Beckman, J.S., Liaudet, L., Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007), 315–424.
67. Thiemermann, C., Inhaled CO: deadly gas or novel therapeutic?. Nat. Med. 7 (2001), 534–535.
68. Wang, P.G., Xian, M., Tang, X., Wu, X., Wen, Z., Cai, T., Janczuk, A.J., Nitric oxide donors: chemical activities and biological applications. Chem. Rev. 102 (2002), 1091–1134.
69. Kim, J., Saravanakumar, G., Choi, H.W., Park, D., Kim, W.J., A platform for nitric oxide delivery. J. Mater. Chem. B 2 (2014), 341–356.
70. Maragos, C.M., Morley, D., Wink, D.A., Dunams, T.M., Saavedra, J.E., Hoffman, A., Bove, A.A., Isaac, L., Hrabie, J.A., Keefer, L.K., Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 34 (1991), 3242–3247.
71. Keefer, L.K., Nims, R.W., Davies, K.M., Wink, D.A., “NONOates” (1-substituted diazen-1-ium-1, 2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268 (1996), 281–293.
72. Hrabie, J.A., Keefer, L.K., Chemistry of the nitric oxide-releasing diazeniumdiolate (“nitrosohydroxylamine”) functional group and its oxygen-substituted derivatives. Chem. Rev. 102 (2002), 1135–1154.
73. Kim, J.S., Ohshima, S., Pediaditakis, P., Lemasters, J.J., Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 39 (2004), 1533–1543.
74. Havelka, G.E., Moreira, E.S., Rodriguez, M.P., Tsihlis, N.D., Wang, Z., Martínez, J., Hrabie, J.A., Kiefer, L.K., Kibbe, M.R., Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury. J. Surg. Res. 180 (2013), 35–42.
75. Singh, R.J., Hogg, N., Joseph, J., Kalyanaraman, B., Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271 (1996), 18596–18603.
76. Haitham, A.-S.D., Ferro, A., S-Nitrosothiols: a class of nitric oxide-donor drugs. Clin. Sci. 98 (2000), 507–520.
77. Garg, U.C., Hassid, A., Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83 (1989), 1774–1777.
78. Khan, M., Jatana, M., Elango, C., Singh Paintlia, A., Singh, A.K., Singh, I., Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15 (2006), 114–124.
79. Rimmer, R.D., Pierri, A.E., Ford, P.C., Photochemically activated carbon monoxide release for biological targets. Toward developing air-stable photoCORMs labilized by visible light. Coord. Chem. Rev. 256 (2012), 1509–1519.
80. Motterlini, R., Clark, J.E., Foresti, R., Sarathchandra, P., Mann, B.E., Green, C.J., Carbon monoxide-releasing molecules characterization of biochemical and vascular activities. Circ. Res. 90 (2002), e17–e24.
81. Foresti, R., Hammad, J., Clark, J.E., Johnson, T.R., Mann, B.E., Friebe, A., Green, C.J., Motterlini, R., Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br. J. Pharmacol. 142 (2004), 453–460.
82. Motterlini, R., Sawle, P., Hammad, J., Bains, S., Alberto, R., Foresti, R., Green, C.J., CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J. 19 (2005), 284–286.
83. He, Q., Kiesewetter, D.O., Qu, Y., Fu, X., Fan, J., Huang, P., Liu, Y., Zhu, G., Liu, Y., Qian, Z., NIR-responsive on-demand release of CO from metal carbonyl-caged graphene oxide nanomedicine. Adv. Mater. 27 (2015), 6741–6746.
84. 2H)}], a new water-soluble CO-releasing molecule. Dalton Trans. 40 (2011), 4230–4235.
85. García-Gallego, S., Bernardes, G.J., Carbon-monoxide-releasing molecules for the delivery of therapeutic CO in vivo. Angew. Chem. Int. Ed. 53 (2014), 9712–9721.
86. Kretschmer, R., Gessner, G., Görls, H., Heinemann, S.H., Westerhausen, M., Dicarbonyl-bis (cysteamine) iron (II): a light induced carbon monoxide releasing molecule based on iron (CORM-S1). J. Inorg. Biochem. 105 (2011), 6–9.
87. Long, L., Jiang, X., Wang, X., Xiao, Z., Liu, X., Water-soluble diiron hexacarbonyl complex as a CO-RM: controllable CO-releasing, releasing mechanism and biocompatibility. Dalton Trans. 42 (2013), 15663–15669.
88. Winburn, I.C., Gunatunga, K., McKernan, R.D., Walker, R.J., Sammut, I.A., Harrison, J.C., Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications. Basic Clin. Pharmacol. Toxicol. 111 (2012), 31–41.
89. Song, H., Zhao, H., Qu, Y., Sun, Q., Zhang, F., Du, Z., Liang, W., Qi, Y., Yang, P., Carbon monoxide releasing molecule-3 inhibits concurrent tumor necrosis factor-α- and interleukin-1β-induced expression of adhesion molecules on human gingival fibroblasts. J. Periodontal Res. 46 (2011), 48–57.
90. Desmard, M., Davidge, K.S., Bouvet, O., Morin, D., Roux, D., Foresti, R., Ricard, J.D., Denamur, E., Poole, R.K., Montravers, P., A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J. 23 (2009), 1023–1031.
91. Li, L., Whiteman, M., Guan, Y.Y., Neo, K.L., Cheng, Y., Lee, S.W., Zhao, Y., Baskar, R., Tan, C.-H., Moore, P.K., Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137) new insights into the biology of hydrogen sulfide. Circulation 117 (2008), 2351–2360.
92. 2S-releasing molecule. Methods Enzymol. 554 (2015), 143–167.
93. Pluth, M.D., Bailey, T.S., Hammers, M.D., Hartle, M.D., Henthorn, H.A., Steiger, A.K., Natural products containing hydrogen sulfide releasing moieties. Synlett 26 (2015), 2633–2643.
94. 2S) donors. J. Am. Chem. Soc. 133 (2010), 15–17.
95. Zhao, Y., Bhushan, S., Yang, C., Otsuka, H., Stein, J.D., Pacheco, A., Peng, B., Devarie-Baez, N.O., Aguilar, H.C., Lefer, D.J., Controllable hydrogen sulfide donors and their activity against myocardial ischemia–reperfusion injury. ACS Chem. Biol. 8 (2013), 1283–1290.
96. Foster, J.C., Powell, C.R., Radzinski, S.C., Matson, J.B., S-Aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics. Org. Lett. 16 (2014), 1558–1561.
97. Lee, M., Tazzari, V., Giustarini, D., Rossi, R., Sparatore, A., Del Soldato, P., McGeer, E., McGeer, P.L., Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J. Biol. Chem. 285 (2010), 17318–17328.
98. Devarie-Baez, N.O., Bagdon, P.E., Peng, B., Zhao, Y., Park, C.M., Xian, M., Light-induced hydrogen sulfide release from “caged” gem-dithiols. Org. Lett. 15 (2013), 2786–2789.
99. Fukushima, N., Ieda, N., Sasakura, K., Nagano, T., Hanaoka, K., Suzuki, T., Miyata, N., Nakagawa, H., Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages. Chem. Commun. 50 (2014), 587–589.
100. Zheng, Y., Yu, B., Ji, K., Pan, Z., Chittavong, V., Wang, B., Esterase-sensitive prodrugs with tunable release rates and direct generation of hydrogen sulfide. Angew. Chem. Int. Ed. 55 (2016), 1–6.
101. 2S) releasing agents: chemistry and biological applications. Chem. Commun. 50 (2014), 11788–11805.
102. Chattopadhyay, M., Kodela, R., Olson, K.R., Kashfi, K., NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. Biochem. Biophys. Res. Commun. 419 (2012), 523–528.
103. Grishenkov, D., Gonon, A., Weitzberg, E., Lundberg, J.O., Harmark, J., Cerroni, B., Paradossi, G., Janerot-Sjoberg, B., Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice. Drug Des. Dev. Ther. 9 (2015), 2409–2419.
104. Mowery, K.A., Schoenfisch, M.H., Saavedra, J.E., Keefer, L.K., Meyerhoff, M.E., Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 21 (2000), 9–21.
105. Duong, H.T., Jung, K., Kutty, S.K., Agustina, S., Adnan, N.N.M., Basuki, J.S., Kumar, N., Davis, T.P., Barraud, N., Boyer, C., Nanoparticle (star polymer) delivery of nitric oxide effectively negates Pseudomonas aeruginosa biofilm formation. Biomacromolecules 15 (2014), 2583–2589.
106. Stasko, N.A., Schoenfisch, M.H., Dendrimers as a scaffold for nitric oxide release. J. Am. Chem. Soc. 128 (2006), 8265–8271.
107. Kim, J., Lee, Y., Singha, K., Kim, H.W., Shin, J.H., Jo, S., Han, D.-K., Kim, W.J., NONOates — polyethylenimine hydrogel for controlled nitric oxide release and cell proliferation modulation. Bioconjug. Chem. 22 (2011), 1031–1038.
108. Nguyen, D., Nguyen, T.-K., Rice, S.A., Boyer, C., CO-releasing polymers exert antimicrobial activity. Biomacromolecules 16 (2015), 2776–2786.
109. Wang, L., Ma, F., Zou, X., Li, Z., Block copolymer nanoparticles as light-induced hydrogen sulfide (H2S) donors. J. Control. Release 213 (2015), e71–e72.
110. 2S-releasing polymers. Macromolecules 47 (2014), 5089–5095.
111. Long, T.R., Wongrakpanich, A., Do, A.-V., Salem, A.K., Bowden, N.B., Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid). Polym. Chem. 6 (2015), 7188–7195.
112. Hasegawa, U., van der Vlies, A.J., Design and synthesis of polymeric hydrogen sulfide donors. Bioconjug. Chem. 25 (2014), 1290–1300.
113. McKinlay, A.C., Xiao, B., Wragg, D.S., Wheatley, P.S., Megson, I.L., Morris, R.E., Exceptional behavior over the whole adsorption–storage–delivery cycle for NO in porous metal organic frameworks. J. Am. Chem. Soc. 130 (2008), 10440–10444.
114. Ma, M., Noei, H., Mienert, B., Niesel, J., Bill, E., Muhler, M., Fischer, R.A., Wang, Y., Schatzschneider, U., Metzler-Nolte, N., Iron metal–organic frameworks MIL-88B and NH2-MIL-88B for the loading and delivery of the gasotransmitter carbon monoxide. Chem. Eur. J. 19 (2013), 6785–6790.
115. Allan, P.K., Wheatley, P.S., Aldous, D., Mohideen, M.I., Tang, C., Hriljac, J.A., Megson, I.L., Chapman, K.W., De Weireld, G., Vaesen, S., Morris, R.E., Metal–organic frameworks for the storage and delivery of biologically active hydrogen sulfide. Dalton Trans. 41 (2012), 4060–4066.
116. Riccio, D.A., Nugent, J.L., Schoenfisch, M.H., Stöber synthesis of nitric oxide-releasing S-nitrosothiol-modified silica particles. Chem. Mater. 23 (2011), 1727–1735.
117. Narin, G., Albayrak, Ç.B., Ülkü, S., Antibacterial and bactericidal activity of nitric oxide-releasing natural zeolite. Appl. Clay Sci. 50 (2010), 560–568.
118. Dördelmann, G., Pfeiffer, H., Birkner, A., Schatzschneider, U., Silicium dioxide nanoparticles as carriers for photoactivatable CO-releasing molecules (PhotoCORMs). Inorg. Chem. 50 (2011), 4362–4367.
119. +. Chem. Commun. 48 (2012), 11528–11530.
120. Hoffman, A.S., Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 64 (2012), 18–23.
121. Seabra, A., Fitzpatrick, A., Paul, J., De Oliveira, M., Weller, R., Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin. Br. J. Dermatol. 151 (2004), 977–983.
122. Lee, K.Y., Mooney, D.J., Hydrogels for tissue engineering. Chem. Rev. 101 (2001), 1869–1880.
123. Matson, J.B., Stupp, S.I., Self-assembling peptide scaffolds for regenerative medicine. Chem. Commun. 48 (2012), 26–33.
124. Rughani, R.V., Salick, D.A., Lamm, M.S., Yucel, T., Pochan, D.J., Schneider, J.P., Folding, self-assembly, and bulk material properties of a de novo designed three-stranded β-sheet hydrogel. Biomacromolecules 10 (2009), 1295–1304.
125. Zhang, S., Holmes, T., Lockshin, C., Rich, A., Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 3334–3338.
126. Stephanopoulos, N., Ortony, J.H., Stupp, S.I., Self-assembly for the synthesis of functional biomaterials. Acta Mater. 61 (2013), 912–930.
127. Berndt, P., Fields, G.B., Tirrell, M., Synthetic lipidation of peptides and amino acids: monolayer structure and properties. J. Am. Chem. Soc. 117 (1995), 9515–9522.
128. Hartgerink, J.D., Beniash, E., Stupp, S.I., Self-assembly and mineralization of peptide–amphiphile nanofibers. Science 294 (2001), 1684–1688.
129. Hartgerink, J.D., Beniash, E., Stupp, S.I., Peptide–amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 5133–5138.
130. Moyer, T.J., Finbloom, J.A., Chen, F., Toft, D.J., Cryns, V.L., Stupp, S.I., pH and amphiphilic structure direct supramolecular behavior in biofunctional assemblies. J. Am. Chem. Soc. 136 (2014), 14746–14752.
131. Matson, J.B., Stupp, S.I., Drug release from hydrazone-containing peptide amphiphiles. Chem. Commun. 47 (2011), 7962–7964.
132. Matson, J.B., Newcomb, C.J., Bitton, R., Stupp, S.I., Nanostructure-templated control of drug release from peptide amphiphile nanofiber gels. Soft Matter 8 (2012), 3586–3595.
133. Storrie, H., Guler, M.O., Abu-Amara, S.N., Volberg, T., Rao, M., Geiger, B., Stupp, S.I., Supramolecular crafting of cell adhesion. Biomaterials 28 (2007), 4608–4618.
134. Goldberger, J.E., Berns, E.J., Bitton, R., Newcomb, C.J., Stupp, S.I., Electrostatic control of bioactivity. Angew. Chem. Int. Ed. 50 (2011), 6292–6295.
135. Silva, G.A., Czeisler, C., Niece, K.L., Beniash, E., Harrington, D.A., Kessler, J.A., Stupp, S.I., Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303 (2004), 1352–1355.
136. Lee, S.S.S., Hsu, E.L., Mendoza, M., Ghodasra, J., Nickoli, M.S., Ashtekar, A., Polavarapu, M., Babu, J., Riaz, R.M., Nicolas, J.D., Nelson, D., Hashmi, S.Z., Kaltz, S.R., Earhart, J.S., Merk, B.R., McKee, J.S., Bairstow, S.F., Shah, R.N., Hsu, W.K., Stupp, S.I., Gel scaffolds of BMP-2-binding peptide amphiphile nanofibers for spinal arthrodesis. Adv. Healthcare Mater., 4, 2015.
137. Paramonov, S.E., Jun, H.W., Hartgerink, J.D., Self-assembly of peptide-amphiphile nanofibers: the roles of hydrogen bonding and amphiphilic packing. J. Am. Chem. Soc. 128 (2006), 7291–7298.
138. Greenfield, M.A., Hoffman, J.R., de la Cruz, M.O., Stupp, S.I., Tunable mechanics of peptide nanofiber gels. Langmuir 26 (2010), 3641–3647.
139. Pashuck, E.T., Cui, H.G., Stupp, S.I., Tuning supramolecular rigidity of peptide fibers through molecular structure. J. Am. Chem. Soc. 132 (2010), 6041–6046.
140. Velichko, Y.S., Stupp, S.I., de la Cruz, M.O., Molecular simulation study of peptide amphiphile self-assembly. J. Phys. Chem. B 112 (2008), 2326–2334.
141. Cui, H., Muraoka, T., Cheetham, A.G., Stupp, S.I., Self-assembly of giant peptide nanobelts. Nano Lett. 9 (2009), 945–951.
142. Pashuck, E.T., Stupp, S.I., Direct observation of morphological tranformation from twisted ribbons into helical ribbons. J. Am. Chem. Soc. 132 (2010), 8819–8821.
143. Cui, H.G., Cheetham, A.G., Pashuck, E.T., Stupp, S.I., Amino acid sequence in constitutionally isomeric tetrapeptide amphiphiles dictates architecture of one-dimensional nanostructures. J. Am. Chem. Soc. 136 (2014), 12461–12468.
144. Matson, J.B., Zha, R.H., Stupp, S.I., Peptide self-assembly for crafting functional biological materials. Curr. Opin. Solid State Mater. Sci. 15 (2011), 225–235.
145. Moyer, T.J., Kassam, H.A., Bahnson, E.S., Morgan, C.E., Tantakitti, F., Chew, T.L., Kibbe, M.R., Stupp, S.I., Shape-dependent targeting of injured blood vessels by peptide amphiphile supramolecular nanostructures. Small 11 (2015), 2750–2755.
146. Sur, S., Tantakitti, F., Matson, J.B., Stupp, S.I., Epitope topography controls bioactivity in supramolecular nanofibers. Biomater. Sci. 3 (2015), 520–532.
147. Webber, M.J., Tongers, J., Newcomb, C.J., Marquardt, K.T., Bauersachs, J., Losordo, D.W., Stupp, S.I., Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 13438–13443.
148. Webber, M.J., Matson, J.B., Tamboli, V.K., Stupp, S.I., Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. Biomaterials 33 (2012), 6823–6832.
149. Majumder, J., Das, M.R., Deb, J., Jana, S.S., Dastidar, P., β-Amino acid and amino-alcohol conjugation of a nonsteroidal anti-inflammatory drug (NSAID) imparts hydrogelation displaying remarkable biostability, biocompatibility, and anti-inflammatory properties. Langmuir 29 (2013), 10254–10263.
150. Conda-Sheridan, M., Lee, S.S., Preslar, A.T., Stupp, S.I., Esterase-activated release of naproxen from supramolecular nanofibres. Chem. Commun. 50 (2014), 13757–13760.
151. Majumder, J., Yedoti, P., Dastidar, P., A supramolecular topical gel derived from a non-steroidal anti-inflammatory drug, fenoprofen, is capable of treating skin inflammation in mice. Org. Biomol. Chem. 13 (2015), 2300–2309.
152. Fleming, S., Ulijn, R.V., Design of nanostructures based on aromatic peptide amphiphiles. Chem. Soc. Rev. 43 (2014), 8150–8177.
153. Vegners, R., Shestakova, I., Kalvinsh, I., Ezzell, R.M., Janmey, P.A., Use of a gel-forming dipeptide derivative as a carrier for antigen presentation. J. Pept. Sci. 1 (1995), 371–378.
154. Azriel, R., Gazit, E., Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide: an experimental support for the key role of the phenylalanine residue in amyloid formation. J. Biol. Chem. 276 (2001), 34156–34161.
155. Reches, M., Gazit, E., Self-assembly of peptide nanotubes and amyloid-like structures by charged-termini-capped diphenylalanine peptide analogues. Isr. J. Chem. 45 (2005), 363–371.
156. Zhou, M., Smith, A.M., Das, A.K., Hodson, N.W., Collins, R.F., Ulijn, R.V., Gough, J.E., Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials 30 (2009), 2523–2530.
157. Fleming, S., Debnath, S., Frederix, P.W.J.M., Tuttle, T., Ulijn, R.V., Aromatic peptide amphiphiles: significance of the Fmoc moiety. Chem. Commun. 49 (2013), 10587–10589.
158. Smith, A.M., Williams, R.J., Tang, C., Coppo, P., Collins, R.F., Turner, M.L., Saiani, A., Ulijn, R.V., Fmoc-diphenylalanine self assembles to a hydrogel via a novel architecture based on π–π interlocked β-sheets. Adv. Mater. 20 (2008), 37–41.
159. Jayawarna, V., Ali, M., Jowitt, T.A., Miller, A.F., Saiani, A., Gough, J.E., Ulijn, R.V., Nanostructured hydrogels for three-dimensional cell culture through self-assembly of fluorenylmethoxycarbonyl-dipeptides. Adv. Mater. 18 (2006), 611–614.
160. Kuang, Y., Xu, B., Disruption of the dynamics of microtubules and selective inhibition of glioblastoma cells by nanofibers of small hydrophobic molecules. Angew. Chem. Int. Ed. 52 (2013), 6944–6948.
161. 5-phenylalanine. Soft Matter 6 (2010), 475–479.
162. Lin, Y., Qiao, Y., Tang, P., Li, Z., Huang, J., Controllable self-assembled laminated nanoribbons from dipeptide-amphiphile bearing azobenzene moiety. Soft Matter 7 (2011), 2762–2769.
163. Huang, Y., Qiu, Z., Xu, Y., Shi, J., Lin, H., Zhang, Y., Supramolecular hydrogels based on short peptides linked with conformational switch. Org. Biomol. Chem. 9 (2011), 2149–2155.
164. 6-fold. J. Am. Chem. Soc. 126 (2004), 15028–15029.
165. Adams, D.J., Topham, P.D., Peptide conjugate hydrogelators. Soft Matter 6 (2010), 3707–3721.
166. Debnath, S., Shome, A., Das, D., Das, P.K., Hydrogelation through self-assembly of Fmoc-peptide functionalized cationic amphiphiles: potent antibacterial agent. J. Phys. Chem. B 114 (2010), 4407–4415.
167. Wang, H., Yang, C., Tan, M., Wang, L., Kong, D., Yang, Z., A structure-gelation ability study in a short peptide-based ‘super hydrogelator’ system. Soft Matter 7 (2011), 3897–3905.
168. Yang, Z., Liang, G., Ma, M., Gao, Y., Xu, B., Conjugates of naphthalene and dipeptides produce molecular hydrogelators with high efficiency of hydrogelation and superhelical nanofibers. J. Mater. Chem. 17 (2007), 850–854.
169. Sutton, S., Campbell, N.L., Cooper, A.I., Kirkland, M., Frith, W.J., Adams, D.J., Controlled release from modified amino acid hydrogels governed by molecular size or network dynamics. Langmuir 25 (2009), 10285–10291.
170. Ryan, D.M., Doran, T.M., Anderson, S.B., Nilsson, B.L., Effect of C-terminal modification on the self-assembly and hydrogelation of fluorinated Fmoc-Phe derivatives. Langmuir 27 (2011), 4029–4039.
171. Hauser, C.A., Zhang, S., Designer self-assembling peptide nanofiber biological materials. Chem. Soc. Rev. 39 (2010), 2780–2790.
172. Zhao, X., Zhang, S., Molecular designer self-assembling peptides. Chem. Soc. Rev. 35 (2006), 1105–1110.
173. Bakota, E.L., Wang, Y., Danesh, F.R., Hartgerink, J.D., Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretome. Biomacromolecules 12 (2011), 1651–1657.
174. Yokoi, H., Kinoshita, T., Zhang, S., Dynamic reassembly of peptide RADA16 nanofiber scaffold. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 8414–8419.
175. Dong, H., Paramonov, S.E., Aulisa, L., Bakota, E.L., Hartgerink, J.D., Self-assembly of multidomain peptides: balancing molecular frustration controls conformation and nanostructure. J. Am. Chem. Soc. 129 (2007), 12468–12472.
176. Micklitsch, C.M., Medina, S.H., Yucel, T., Nagy-Smith, K.J., Pochan, D.J., Schneider, J.P., Influence of hydrophobic face amino acids on the hydrogelation of β-hairpin peptide amphiphiles. Macromolecules 48 (2015), 1281–1288.
177. Aggeli, A., Bell, M., Carrick, L.M., Fishwick, C.W.G., Harding, R., Mawer, P.J., Radford, S.E., Strong, A.E., Boden, N., pH as a trigger of peptide β-sheet self-sssembly and reversible switching between nematic and isotropic phases. J. Am. Chem. Soc. 125 (2003), 9619–9628.
178. Collier, J.H., Messersmith, P.B., Enzymatic modification of self-assembled peptide structures with tissue transglutaminase. Bioconjug. Chem. 14 (2003), 748–755.
179. Galler, K.M., Aulisa, L., Regan, K.R., D'Souza, R.N., Hartgerink, J.D., Self-assembling multidomain peptide hydrogels: designed susceptibility to enzymatic cleavage allows enhanced cell migration and spreading. J. Am. Chem. Soc. 132 (2010), 3217–3223.
180. Kang, M.K., Colombo, J.S., D'Souza, R.N., Hartgerink, J.D., Sequence effects of self-assembling multidomain peptide hydrogels on encapsulated SHED cells. Biomacromolecules 15 (2014), 2004–2011.
181. Yan, C., Altunbas, A., Yucel, T., Nagarkar, R.P., Schneider, J.P., Pochan, D.J., Injectable solid hydrogel: mechanism of shear-thinning and immediate recovery of injectable β-hairpin peptide hydrogels. Soft Matter 6 (2010), 5143–5156.
182. Lindsey, S., Piatt, J.H., Worthington, P., Sonmez, C., Satheye, S., Schneider, J.P., Pochan, D.J., Langhans, S.A., Beta hairpin peptide hydrogels as an injectable solid vehicle for neurotrophic growth factor delivery. Biomacromolecules 16 (2015), 2672–2683.
183. Kyle, S., Felton, S.H., McPherson, M.J., Aggeli, A., Ingham, E., Rational molecular design of complementary self-assembling peptide hydrogels. Adv. Healthcare Mater. 1 (2012), 640–645.
184. Aggeli, A., Bell, M., Boden, N., Keen, J.N., Knowles, P.F., McLeish, T.C.B., Pitkeathly, M., Radford, S.E., Responsive gels formed by the spontaneous self-assembly of peptides into polymeric beta-sheet tapes. Nature 386 (1997), 259–262.
185. Aggeli, A., Bell, M., Boden, N., Keen, J.N., McLeish, T.C.B., Nyrkova, I., Radford, S.E., Semenov, A., Engineering of peptide beta-sheet nanotapes. J. Mater. Chem. 7 (1997), 1135–1145.
186. Aggeli, A., Nyrkova, I., Bell, M., Harding, R., Carrick, L., McLeish, T., Semenov, A., Boden, N., Hierarchical self-assembly of chiral rod-like molecules as a model for peptide β-sheet tapes, ribbons, fibrils, and fibers. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 11857–11862.
187. Scanlon, S., Aggeli, A., Self-assembling peptide nanotubes. Nano Today 3 (2008), 22–30.
188. Jung, J.P., Jones, J.L., Cronier, S.A., Collier, J.H., Modulating the mechanical properties of self-assembled peptide hydrogels via native chemical ligation. Biomaterials 29 (2008), 2143–2151.
189. Jung, J.P., Nagaraj, A.K., Fox, E.K., Rudra, J.S., Devgun, J.M., Collier, J.H., Co-assembling peptides as defined matrices for endothelial cells. Biomaterials 30 (2009), 2400–2410.
190. Gasiorowski, J.Z., Collier, J.H., Directed intermixing in multicomponent self-assembling biomaterials. Biomacromolecules 12 (2011), 3549–3558.
191. Haines-Butterick, L., Rajagopal, K., Branco, M., Salick, D., Rughani, R., Pilarz, M., Lamm, M.S., Pochan, D.J., Schneider, J.P., Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 7791–7796.
192. Schneider, J.P., Pochan, D.J., Ozbas, B., Rajagopal, K., Pakstis, L., Kretsinger, J., Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. J. Am. Chem. Soc. 124 (2002), 15030–15037.
193. Ramachandran, S., Trewhella, J., Tseng, Y., Yu, Y.B., Coassembling peptide-based biomaterials: effects of pairing equal and unequal chain length oligopeptides. Chem. Mater. 18 (2006), 6157–6162.
194. Guvendiren, M., Lu, H.D., Burdick, J.A., Shear-thinning hydrogels for biomedical applications. Soft Matter 8 (2012), 260–272.
195. Guo, C.X., Ng, S.R., Khoo, S.Y., Zheng, X., Chen, P., Li, C.M., RGD-peptide functionalized graphene biomimetic live-cell sensor for real-time detection of nitric oxide molecules. ACS Nano 6 (2012), 6944–6951.
196. 2S. Chem. Commun. 51 (2015), 17273–17276.
197. Rajangam, K., Arnold, M.S., Rocco, M.A., Stupp, S.I., Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. Biomaterials 29 (2008), 3298–3305.
198. Kapadia, M.R., Chow, L.W., Tsihlis, N.D., Ahanchi, S.S., Hrabie, J.A., Murar, J., Martinez, J., Popowich, D.A., Jiang, Q., Hrabie, J.A., Saavedra, J.E., Keefer, L.K., Hulvat, J.F., Stupp, S.I., Kibbe, M.P., Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J. Vasc. Surg. 47 (2008), 173–182.
199. Kassam, H., Moreira, E., Moyer, T., Stupp, S., Kibbe, M., Prevention of neointimal hyperplasia with systemic injection of a targeted drug-eluting peptide amphiphile. J. Surg. Res. 179 (2013), 296–297.
200. Kushwaha, M., Anderson, J.M., Bosworth, C.A., Andukuri, A., Minor, W.P., Lancaster, J.R. Jr., Anderson, P.G., Brott, B.C., Jun, H.-W., A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices. Biomaterials 31 (2010), 1502–1508.
201. Lim, D.-J., Andukuri, A., Vines, J.B., Rahman, S.M., Hwang, P.T., Kim, J., Shalev, A., Corbett, J.A., Jun, H.-W., Enhanced MIN-6 beta cell survival and function on a nitric oxide-releasing peptide amphiphile nanomatrix. Int. J. Nanomedicine, 9, 2014, 13.
202. Gao, J., Zheng, W., Zhang, J., Guan, D., Yang, Z., Kong, D., Zhao, Q., Enzyme-controllable delivery of nitric oxide from a molecular hydrogel. Chem. Commun. 49 (2013), 9173–9175.
203. Legigan, T., Clarhaut, J., Tranoy-Opalinski, I., Monvoisin, A., Renoux, B., Thomas, M., Le Pape, A., Lerondel, S., Papot, S., The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy. Angew. Chem. Int. Ed. 51 (2012), 11606–11610.
204. Yao, X., Liu, Y., Gao, J., Yang, L., Mao, D., Stefanitsch, C., Li, Y., Zhang, J., Ou, L., Kong, D., Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. Biomaterials 60 (2015), 130–140.
205. +-based CO releasing molecules (tpm = tris(pyrazolyl)methane). Dalton Trans. 22 (2009), 4292–4298.
206. 2: photoactivated carbon monoxide release, growth inhibitory activity, and peptide ligation. Inorg. Chem. 50 (2011), 5336–5338.
207. Matson, J.B., Webber, M.J., Tamboli, V.K., Weber, B., Stupp, S.I., A peptide-based material for therapeutic carbon monoxide delivery. Soft Matter 8 (2012), 6689–6692.
208. Carter, J.M., Qian, Y., Foster, J.C., Matson, J.B., Peptide-based hydrogen sulphide-releasing gels. Chem. Commun. 51 (2015), 13131–13134.
209. Goldstein, B., Baldassarre, J., Young, J.N., Effects of inhaled nitric oxide on hemostasis in healthy adults treated with heparin: a randomized, controlled, blinded crossover study. Thromb. J., 10, 2012, 1.
210. Napoli, C., Cirino, G., Del Soldato, P., Sorrentino, R., Sica, V., Condorelli, M., Pinto, A., Ignarro, L.J., Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 2860–2864.
211. Nagasaka, Y., Fernandez, B.O., Garcia-Saura, M.F., Petersen, B., Ichinose, F., Bloch, K.D., Feelisch, M., Zapol, W.M., Brief periods of nitric oxide inhalation protect against myocardial ischemia–reperfusion injury. Anesthesiology 109 (2008), 675–682.
212. Perrotta, C., Falcone, S., Capobianco, A., Camporeale, A., Sciorati, C., De Palma, C., Pisconti, A., Rovere-Querini, P., Bellone, M., Manfredi, A.A., Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma. Cancer Res. 64 (2004), 3767–3771.
213. Morrison, M.L., Blackwood, J.E., Lockett, S.L., Iwata, A., Winn, R.K., Roth, M.B., Surviving blood loss using hydrogen sulfide. J. Trauma Acute Care Surg. 65 (2008), 183–188.
214. Chuah, S.C., Moore, P.K., Zhu, Y.Z., S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H2693–H2701.
215. Ramasamy, S., Singh, S., Taniere, P., Langman, M., Eggo, M., Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006), G288–G296.
216. Hu, J., Whittaker, M.R., Duong, H., Li, Y., Boyer, C., Davis, T.P., Biomimetic polymers responsive to a biological signaling molecule: nitric oxide triggered reversible self-assembly of single macromolecular chains into nanoparticles. Angew. Chem. Int. Ed. 53 (2014), 7779–7784.
217. Hu, J., Whittaker, M.R., Yu, S.H., Quinn, J.F., Davis, T.P., Nitric oxide (NO) cleavable biomimetic Thermoresponsive double hydrophilic diblock copolymer with tunable LCST. Macromolecules 48 (2015), 3817–3824.